Pharmacotherapies for Post‐Bariatric Weight Regain: Real‐World Comparative Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacotherapies for Post‐Bariatric Weight Regain: Real‐World Comparative Outcomes

Published:2021-04-04 Issue:5 Volume:29 Page:829-836
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Gazda Chellse L.¹^ORCID,Clark John D.²,Lingvay Ildiko¹³,Almandoz Jaime P.¹

Affiliation:

1. Division of Endocrinology Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA

2. Division of General Internal Medicine Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA

3. Department of Population and Data Sciences University of Texas Southwestern Medical Center Dallas Texas USA

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23146

Reference32 articles.

1. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes

2. Cardiovascular benefits of bariatric surgery

3. Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020: Estimates of Diabetes and Its Burden in the United States

4. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Therapies;Gastrointestinal Endoscopy Clinics of North America;2024-10

2. Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings;Obesity Pillars;2024-09

3. Stronger control of eating 3 months after sleeve gastrectomy predicts successful weight loss outcomes at one year;Obesity Pillars;2024-09

4. A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0mg for weight recurrence after Roux-en-Y gastric-bypass;Surgery for Obesity and Related Diseases;2024-09

5. The Patient’s Journey in Obesity within the United States: An Exercise of Resilience against Disease;Life;2024-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3